These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 30136445

  • 1. A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics.
    Tettelbach W, Cazzell S, Reyzelman AM, Sigal F, Caporusso JM, Agnew PS.
    Int Wound J; 2019 Feb; 16(1):19-29. PubMed ID: 30136445
    [Abstract] [Full Text] [Related]

  • 2. A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion/chorion membrane (EpiFix® ) allograft for the treatment of venous leg ulcers.
    Bianchi C, Cazzell S, Vayser D, Reyzelman AM, Dosluoglu H, Tovmassian G, EpiFix VLU Study Group.
    Int Wound J; 2018 Feb; 15(1):114-122. PubMed ID: 29024419
    [Abstract] [Full Text] [Related]

  • 3. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W, Cazzell S, Sigal F, Caporusso JM, Agnew PS, Hanft J, Dove C.
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [Abstract] [Full Text] [Related]

  • 4. The Use of Micronized Dehydrated Human Amnion/Chorion Membrane Allograft for the Treatment of Diabetic Foot Ulcers: A Case Series.
    Hawkins B.
    Wounds; 2016 May; 28(5):152-7. PubMed ID: 27191173
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An evaluation of dehydrated human amnion/chorion membrane allografts for pressure ulcer treatment: a case series.
    Berhane CC, Brantley K, Williams S, Sutton E, Kappy C.
    J Wound Care; 2019 May 01; 28(Sup5):S4-S10. PubMed ID: 31067170
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Comparative Effectiveness of a Human Fibroblast Dermal Substitute versus a Dehydrated Human Amnion/Chorion Membrane Allograft for the Treatment of Diabetic Foot Ulcers in a Real-world Setting.
    Kraus I, Sabolinski ML, Skornicki M, Parsons NB.
    Wounds; 2017 May 01; 29(5):125-132. PubMed ID: 28570252
    [Abstract] [Full Text] [Related]

  • 12. Dehydrated human amnion/chorion tissue in difficult-to-heal DFUs: a case series.
    Penny H, Rifkah M, Weaver A, Zaki P, Young A, Meloy G, Flores R.
    J Wound Care; 2015 Mar 01; 24(3):104; 106-9; 111. PubMed ID: 25764954
    [Abstract] [Full Text] [Related]

  • 13. A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers.
    Zelen CM, Gould L, Serena TE, Carter MJ, Keller J, Li WW.
    Int Wound J; 2015 Dec 01; 12(6):724-32. PubMed ID: 25424146
    [Abstract] [Full Text] [Related]

  • 14. A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion/chorion membrane allograft in the management of diabetic foot ulcers.
    Zelen CM, Serena TE, Snyder RJ.
    Int Wound J; 2014 Apr 01; 11(2):122-8. PubMed ID: 24618401
    [Abstract] [Full Text] [Related]

  • 15. Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial.
    Cazzell SM, Caporusso J, Vayser D, Davis RD, Alvarez OM, Sabolinski ML.
    J Wound Care; 2024 Jul 01; 33(Sup7):S4-S14. PubMed ID: 38973638
    [Abstract] [Full Text] [Related]

  • 16. Comparative effectiveness of a bioengineered living cellular construct vs. a dehydrated human amniotic membrane allograft for the treatment of diabetic foot ulcers in a real world setting.
    Kirsner RS, Sabolinski ML, Parsons NB, Skornicki M, Marston WA.
    Wound Repair Regen; 2015 Sep 01; 23(5):737-44. PubMed ID: 26100572
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of dehydrated human amnion/chorion membrane allografts in lower extremity diabetic ulcer treatment.
    Tettelbach WH, Armstrong DG, Chang TJ, Jong JL, Glat PM, Hsu JH, Kelso MR, Niezgoda JA, Labovitz JM, Hubbs B, Forsyth RA, Cohen BG, Reid NM, Padula WV.
    J Wound Care; 2022 Feb 01; 31(Sup2):S10-S31. PubMed ID: 35148642
    [Abstract] [Full Text] [Related]

  • 18. Pain reduction by dehydrated human amnion/chorion membrane allograft in nondiabetic leg ulcers might be an early indicator of good response: A case series.
    Mueller SM, Navarini AA, Itin P, Schwegler S, Laeuchli S, Goldust M, Ivanova K.
    Dermatol Ther; 2020 Jul 01; 33(4):e13587. PubMed ID: 32410269
    [Abstract] [Full Text] [Related]

  • 19. Biological properties of dehydrated human amnion/chorion composite graft: implications for chronic wound healing.
    Koob TJ, Rennert R, Zabek N, Massee M, Lim JJ, Temenoff JS, Li WW, Gurtner G.
    Int Wound J; 2013 Oct 01; 10(5):493-500. PubMed ID: 23902526
    [Abstract] [Full Text] [Related]

  • 20. The influence of adequate debridement and placental-derived allografts on diabetic foot ulcers.
    Tettelbach WH, Cazzell SM, Hubbs B, Jong JL, Forsyth RA, Reyzelman AM.
    J Wound Care; 2022 Sep 01; 31(Sup9):S16-S26. PubMed ID: 36113857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.